Literature DB >> 1482707

Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482707     DOI: 10.1089/hum.1992.3.6-665

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  5 in total

Review 1.  Gene therapy in pediatric oncology.

Authors:  E Benaim; B P Sorrentino
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 2.  A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme.

Authors:  Thomas Wirth
Journal:  World J Exp Med       Date:  2011-12-20

Review 3.  Viral vectors for gene transfer: a review of their use in the treatment of human diseases.

Authors:  W Walther; U Stein
Journal:  Drugs       Date:  2000-08       Impact factor: 11.431

4.  Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.

Authors:  Nan Ji; Danhui Weng; Cang Liu; Zheng Gu; Shizhang Chen; Ying Guo; Zhong Fan; Xiao Wang; Jianfei Chen; Yanyan Zhao; Jianfeng Zhou; Jisheng Wang; Ding Ma; Ning Li
Journal:  Oncotarget       Date:  2016-01-26

Review 5.  Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.

Authors:  M A Rogy; Julie M Baumhofer; Britta Beinhauer; H Brandmeier; P Eisenburger; U M Losert; Ramila Philip
Journal:  Acta Chir Austriaca       Date:  1997
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.